Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
Scope of the Report:Currently, there are many sales companies in the world Aprotinin industry, especially in India and China. The main market players are Sigma-Aldrich, BeiJing Geyuantianrun Bio-tech, Cayman Chemical, Taj Pharmaceuticals Limited and Guangdong Techpool Bio-pharma. The sale Revenue of Aprotinin is about 123458 K USD in 2015.
North America is the largest consumption region of Aprotinin, with a Revenue market share nearly 20.28% in 2015.
The second consumption place is Europe; following North America with the Revenue market share of 19.66%. China is another important market of Aprotinin, enjoying 17.23% Revenue market share.
Aprotinin is used in Pharmaceuticals and Scientific Research & Experiment areas. Report data showed that 74.04% of the Aprotinin market demand in Pharmaceuticals and 25.96% in Scientific Research & Experiment areas in 2015.
There are three kinds of Aprotinin, which are Aprotinin (From bovine lung) and Recombinant Aprotinin. Aprotinin (From bovine lung) is wildly used in the Aprotinin, with a revenue market share nearly 81.11% in 2015.
Briefly speaking, in the next few years, Aprotinin industry will still be a highly energetic industry. Sales of Aprotinin have brought a lot of opportunities, there will more companies enter into this industry, especially in developing countries.
The worldwide market for Aprotinin is expected to grow at a CAGR of roughly 4.7% over the next five years, will reach 180 million US$ in 2026, from 140 million US$ in 2020, according to a new Our study.
This report focuses on the Aprotinin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers Sigma-Aldrich
BeiJing Geyuantianrun Bio-tech
Cayman Chemical
Taj Pharmaceuticals Limited
Guangdong Techpool Bio-pharma
Dadeli
A.S.Joshi&Company
Enzymeking Biotechnology
AdooQ BioScience
ProSpec
Yaxin Biotechnology
AMRESCO
PanReac AppliChem
Runhao
Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers Aprotinin (From bovine lung)
Recombinant Aprotinin
Market Segment by Applications, can be divided into Pharmaceuticals
Scientific Research & Experiment
The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Aprotinin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Aprotinin, with price, sales, revenue and global market share of Aprotinin in 2018 and 2019.
Chapter 3, the Aprotinin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aprotinin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Aprotinin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2026.
Chapter 13, 14 and 15, to describe Aprotinin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.